Back to Search
Start Over
Discovery of 4,6‐bis(2‐((E)‐benzylidene)hydrazinyl)pyrimidin‐2‐Amine with Antibiotic Activity.
- Source :
-
ChemistryOpen . Jul2019, Vol. 8 Issue 7, p896-907. 12p. - Publication Year :
- 2019
-
Abstract
- Robenidine (E)‐N′‐((E)‐1‐(4‐chlorophenyl)ethylidene)‐2‐(1‐(4‐chlorophenyl)ethylidene)hydrazine‐1‐carboximidhydrazide displays methicillin‐resistant Staphyoccoccus aureus (MRSA) and vancomycin‐resistant Enterococci (VRE) MICs of 2 μg mL−1. Herein we describe the structure‐activity relationship development of a novel series of guanidine to 2‐aminopyrimidine isosteres that ameliorate the low levels of mammalian cytotoxicity in the lead compound while retaining good antibiotic activity. Removal of the 2‐NH2 pyrimidine moiety renders these analogues inactive. Introduction of a central 2‐NH2 triazine moiety saw a 10‐fold activity reduction. Phenyl to cyclohexyl isosteres were inactive. The 4‐BrPh and 4‐CH3Ph with MIC values of 2 and 4 μg mL−1, against MRSA and VRE respectively, are promising candidates for future development. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 21911363
- Volume :
- 8
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- ChemistryOpen
- Publication Type :
- Academic Journal
- Accession number :
- 137796022
- Full Text :
- https://doi.org/10.1002/open.201800241